Nitric oxide in coronary artery disease: Effects of antioxidants
In this review article we examine the main mechanisms leading to decreased nitric oxide (NO) bioavailability, and we present the current strategies available to increase NO levels, mainly by using antioxidants in patients with coronary artery disease. Decreased NO bioavailability in the vasculature...
Main Authors: | Tousoulis, D, Antoniades, C, Stefanadis, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2006
|
Similar Items
-
Effects of endothelial nitric oxide synthase gene polymorphisms on oxidative stress, inflammatory status, and coronary atherosclerosis: an example of a transient phenotype.
by: Antoniades, C, et al.
Published: (2007) -
Nitric oxide-releasing aspirin: will it say NO to atherothrombosis?
by: Antoniades, C, et al.
Published: (2007) -
The oxidative stress menace to coronary vasculature: any place for antioxidants?
by: Briasoulis, A, et al.
Published: (2009) -
Statins ameliorate atherosclerosis induced by inhibition of nitric oxide synthase: another novel vascular protective mechanism?
by: Tousoulis, D, et al.
Published: (2008) -
Letter regarding article by Becker et al, "Hyperhomocysteinemia, a cardiac metabolic disease: role of nitric oxide and the p22phox subunit of NADPH oxidase".
by: Antoniades, C, et al.
Published: (2005)